2,258
Views
30
CrossRef citations to date
0
Altmetric
Research Article

Screening of medicinal plants against Leishmania amazonensis

, , &
Pages 1053-1058 | Received 01 Aug 2008, Accepted 13 Nov 2009, Published online: 23 Aug 2010
 

Abstract

Context: Leishmaniasis is a widespread tropical infection caused by different species of Leishmania protozoa. There is no immunoprophylaxis (vaccination) available for Leishmania infections and conventional treatments are unsatisfactory; therefore antileishmanial drugs are urgently needed. Natural products are attractive due to their structural diversity.

Objective: The present work investigated the antileishmanial action of 21 species of plants.

Materials and methods: Plants were collected and their hydroalcoholic extracts were screened against promastigotes and amastigotes of L. amazonensis. Their toxicity was also assayed against peritoneal macrophages from BALB/c mice.

Results: Five extracts showed significant growth inhibitory activity against promastigote form. Only the extracts from Bidens pilosa L. (Asteraceae) and Punica granatum L. (Punicaceae) inhibited the growth of intracellular amastigotes, with IC50 values of 42.6 and 69.6 µg/mL, respectively. In addition, a low toxicity on macrophage from BALB/c mice was observed.

Discussion: The antiparasitic activities of B. pilosa and P. granatum have been reported against other parasitic agents and their actions can be the results of flavonoids present in the extracts.

Conclusion: This study supports the importance of natural products as potential sources in the search for new antileishmanial drugs.

Acknowledgment

Thanks to Sheila Cabezas for helpful advice and revision of the paper.

Declaration of interest

The authors report no conflict of interest and have received no payment in preparation of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.